연구성과로 돌아가기

2025 연구자 정보 (441 / 657)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Ha, Ji Yong
(Ha, JY) ⓘ 		Keimyung Univ, Dongsan Hosp, Daegu, South Korea ⓘ KSM-0577-2024
Ha, Ji Yong ⓘ
ⓘ 		[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ ksleemd@dsmc.or.kr; ⓘ
Ha, U-Syn
(Ha, US) ⓘ 		Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Urol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ skhong@snubh.org; urojy@ncc.re.kr; ⓘ
Hah, Yoon Soo
(Hah, YS) ⓘ 		Daegu Catholic Univ, Med Ctr, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ ksleemd@dsmc.or.kr; ⓘ
Han, Hyun Ho
(Han, HH) ⓘ 		Yonsei Univ, Urol Sci Inst, Dept Urol, Coll Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ skhong@snubh.org; urojy@ncc.re.kr; ⓘ
Hong, Sung Kyu
(Hong, SK) ⓘ 		교신저자 Univ Ulsan, Dept Urol, Ulsan Univ Hosp, Coll Med, Ulsan, South Korea
Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Urol, Seongnam, South Korea
Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
Dongguk Univ, Dept Chem & Biochem Engn, Seoul 04620, South Korea ⓘ 		J-5722-2012
Hong, Sung ⓘ
ⓘ 		[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea
[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia
[JCR상위 22.4] Identification of Phytosphingosine-Based 1-O-Acylceramide in Human Stratum Corneum and Investigation of Its Role in Skin Barrier ⓘ 		SCIE
ESCI ⓘ 		22.4 UROLOGY & NEPHROLOGY
BIOCHEMISTRY & MOLECULAR BIOLOGY;DERMATOLOGY ⓘ 		skhong@snubh.org; urojy@ncc.re.kr;
ksleemd@dsmc.or.kr;
baegon0709@naver.com; bluentia@naver.com; dstlkh@knu.ac.kr; hsk5457@dongguk.edu; deacne@lcsbio.com; leeeunok@lcsbio.com; csp54@lcsbio.com; ⓘ
Il Chung, Jae
(Il Chung, J) ⓘ 		Inje Univ, Busan Paik Hosp, Coll Med, Dept Urol, Busan, South Korea
Inje Univ, Busan Paik Hosp, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea
[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia ⓘ 		SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ skhong@snubh.org; urojy@ncc.re.kr;
ksleemd@dsmc.or.kr; ⓘ
Il Seo, Seong
(Il Seo, S) ⓘ 		Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ skhong@snubh.org; urojy@ncc.re.kr; ⓘ
Jeon, Hwang Gyun
(Jeon, HG) ⓘ 		Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ skhong@snubh.org; urojy@ncc.re.kr; ⓘ
Jeon, Youn Soo
(Jeon, YS) ⓘ 		Soonchunhyang Univ Hosp, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ ksleemd@dsmc.or.kr; ⓘ
Jeong, In Gab
(Jeong, IG) ⓘ 		Seoul Asan Med Ctr, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ ksleemd@dsmc.or.kr; ⓘ
Joung, Jae Young
(Joung, JY) ⓘ 		교신저자 Natl Canc Ctr, Ctr Urol Canc, Goyang, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ skhong@snubh.org; urojy@ncc.re.kr; ⓘ
Kang, Seokhyeong
(Kang, S) ⓘ 		Pohang Univ Sci & Technol, Dept Elect Engn, Cheongam Ro 77, Pohang 37673, Gyeongbuk, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] An area and power efficient ternary serial adder using phase composite ZnO stack channel FETs ⓘ SCIE ⓘ 31.2 CHEMISTRY, MULTIDISCIPLINARY;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY ⓘ bhlee1@postech.ac.kr; ⓘ
Kang, Taek Won
(Kang, TW) ⓘ 		Chonnam Natl Univ, Chonnam Natl Univ Hosp, Dept Urol, Med Sch, Gwangju, South Korea
Chonnam Natl Univ Hosp, Gwangju, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea
[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia ⓘ 		SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ skhong@snubh.org; urojy@ncc.re.kr;
ksleemd@dsmc.or.kr; ⓘ
Kim, Byung Hoon
(Kim, BH) ⓘ 		Keimyung Univ, Dongsan Hosp, Sch Med, Dept Urol, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ skhong@snubh.org; urojy@ncc.re.kr; ⓘ
Kim, Jang Hwan
(Kim, JH) ⓘ 		Severance Hosp, Ilsan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 31.2] A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia ⓘ SCIE ⓘ 31.2 UROLOGY & NEPHROLOGY ⓘ ksleemd@dsmc.or.kr; ⓘ
페이지 이동: